Periungual pyogenic granuloma following imatinib therapy in a patient with chronic myelogenous leukemia
Dika, E.; Barisani, A.; Vaccari, S.; Fanti, P.A.; Ismaili, A.; Patrizi, A.
Journal of Drugs in Dermatology Jdd 12(5): 512-513
2013
ISSN/ISBN: 1545-9616 PMID: 23652942 Document Number: 14020
Document emailed within 1 workday
Related Documents
Resenstein, R.; Lewellis, S.; Leger, M. 2015: Periungual pyogenic granuloma formation in a patient with complex regional pain syndrome Dermatology Online Journal 21(12)Wong, M.; Sade, S.; Gilbert, M.; Klieb, H.B.E. 2011: Oral melanosis after tyrosine kinase inhibition with Imatinib for chronic myelogenous leukemia: report of a case and review of the literature Dermatology Online Journal 17(5): 4
Usman, M.; Kakepoto, G.N.; Adil, S.N.; Sajid, R.; Arain, S.; Khurshid, M. 2004: Hematologic and cytogenetic findings in eleven chronic myelogenous leukemia patients treated with imatinib mesylate at a tertiary care hospital Jpma. Journal of the Pakistan Medical Association 54(1): 17-20
Weisser, M.; Tischer, J.; Schnittger, S.; Schoch, C.; Ledderose, G.; Kolb, H.Jochem. 2006: A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation Haematologica 91(5): 663-666
Paul, L.J.; Cohen, P.R. 2012: Paclitaxel-associated subungual pyogenic granuloma: report in a patient with breast cancer receiving paclitaxel and review of drug-induced pyogenic granulomas adjacent to and beneath the nail Journal of Drugs in Dermatology: Jdd 11(2): 262-268
Sung, Y.; Kim, M.Hee.; Cho, E. 2019: Successful hyaluronic acid filler injection in a chronic myeloid leukemia patient taking imatinib mesylate Journal of Cosmetic and Laser Therapy 21(4): 243-244
Cervantes, F.; Hernández-Boluda, J-Carlos.; Steegmann, J-Luis.; Conde, E.; Alvarez-Larrán, A.; López-Jiménez, J.; Osorio, S.; Villalón, Lía.; Camós, M.; García-Conde, J.; Odriozola, Jús. 2003: Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients Haematologica 88(10): 1117-1122
Molnár, L.; Nagy, A.; Dávid, M.; Szomor, A.ád.; Méhes, G.áb.; Kovács, G.áb.; Losonczy, H. 2004: Results of imatinib therapy in late-stage chronic myeloid leukemia after treatment with interferon-alpha Orvosi Hetilap 145(17): 901-907
Talpaz, M.; Kantarjian, H.M.; Kurzrock, R.; Gutterman, J. 1988: Therapy of chronic myelogenous leukemia: chemotherapy and interferons Seminars in Hematology 25(1): 62-73
Jentsch-Ullrich, K.; Pelz, A-Friederike.; Braun, H.; Koenigsmann, M.; Mohren, M.; Wieacker, P.; Franke, A. 2004: Complete molecular remission in a patient with Philadelphia-chromosome positive acute myeloid leukemia after conventional therapy and imatinib Haematologica 89(5): Ecr15
Guilhot, F.; Dreyfus, B.; Desmarest, M.C.; Giraud, C.; Huret, J.L.; Brizard, A.; Tanzer, J. 1989: Combined therapy interferon and chemotherapy in chronic myelogenous leukemia Nouvelle Revue Francaise d'Hematologie 31(2): 171-173
Uzuka, Y.; Saito, Y. 1991: Combination therapy of chronic myelogenous leukemia with busulfan and bestatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(4): 571-578
Kishi, K.; Takahashi, M.; Aoki, S.; Nagai, K.; Hirosawa, H.; Koike, T.; Sakai, C.; Aoyagi, Y.; Sanada, M.; Moriyama, Y. 1984: A new Ph1 positive cell line (KU812) from a patient with blastic crisis of chronic myelogenous leukemia Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 47(3): 709-718
Galos, D.; Chowdhury, F.R.; Gupta, R.; Heman-Ackah, Y.D.; Sataloff, R.T. 2014: Recurrent pyogenic granuloma in a noncompliant patient Ear Nose and Throat Journal 93(1): E32-E33
McGlave, P.B. 1992: Therapy of chronic myelogenous leukemia with related or unrelated donor bone marrow transplantation Leukemia 6(Suppl 4): 115-117
Opalka, B.; Wandl, U.; Beer, U.; Roggenbuck, U.; Kloke, O.; Niederle, N. 1991: Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapy Leukemia 5(6): 452-456
Schirren, C.G.; Schlag, R.; Eckert, F.; Spann, W.; Meurer, M.; Kaudewitz, P.; Krieg, T. 1991: Multilocular, immature-cell myelogenous infiltrates of the skin in a patient with chronic myelomonocytic leukemia following polycythemia vera and anti-cardiolipin syndrome Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 42(4): 258-262
Reiffers, J.; Goldman, J.; Meloni, G.; Cahn, J.Y.; Gratwohl, A. 1994: Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT Bone Marrow Transplantation 14(3): 407-410
Dhingra, K.; Talpaz, M.; Kantarjian, H.; Ku, S.; Rothberg, J.; Gutterman, J.U.; Kurzrock, R. 1991: Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression Leukemia 5(3): 191-195
Santos, G.W. 1988: Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia Cancer Detection and Prevention 12(1-6): 589-596